Genelux announces promising data from two phase I trials of GL-ONC1 in head and neck cancer and mesothelioma

Genelux Corporation, a clinical-stage biopharmaceutical company focused on the development of vaccinia virus for oncolytic immunotherapy, today a...

May 28, 2015 by moderator with 0 comments

Smoking a significant predictor of lung cancer recurrence in survivors

In 2015, an estimated 158,040 Americans are expected to die from lung cancer, making it the leading cause of cancer death in this country. Lung c...

May 20, 2015 by moderator with 0 comments

Canada should ban asbestos use in Canada and globally

To prevent future cases of asbestos-related disease, Canada should institute a time-specific ban on asbestos use in Canada and support a global b...

May 5, 2015 by moderator with 0 comments